Corrine Miller, PA
Medical · Noblesville, INNPI 1669225215
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AstraZeneca at 25.4% of the total.
Across 105 payments — averaging $23.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$621
- GSK$246
- United Therapeutics Corporation$229
- Regeneron Healthcare Solutions, Inc.$215
- Sanofi$132
- Jazz Pharmaceuticals Inc.$128
- plus $876 from 17 others
What the payments were for
- Food & beverage$2,34896%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 23 | $621 |
| GSK | 15 | $246 |
| United Therapeutics Corporation | 9 | $229 |
| Regeneron Healthcare Solutions, Inc. | 10 | $215 |
| Sanofi | 6 | $132 |
| Jazz Pharmaceuticals Inc. | 5 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $108 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Merck | 3 | $79 |
| Paratek Pharmaceuticals, Inc. | 4 | $69 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $68 |
| Mylan Specialty L.p. | 3 | $60 |
| Verona Pharma, Inc. | 3 | $58 |
| Viatris Specialty LLC | 3 | $55 |
| Actelion Pharmaceuticals US, Inc. | 2 | $49 |
| Fisher & Paykel Healthcare Inc | 2 | $46 |
| Lilly USA, LLC | 2 | $40 |
| Harmony Biosciences LLC | 1 | $38 |
| Boehringer Ingelheim | 1 | $28 |
| Grifols USA, LLC | 1 | $23 |
| CSL Behring | 1 | $23 |
| Pulmonx Corporation | 1 | $17 |
| Chiesi USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEZSPIRE$116
How this compares
$2,448 in reported general payments places this provider in the 80th percentile of 273 medical providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 17 | $113 |
| Doxycycline Hyclate | 14 | $51 |
Paid to pharmacies, not to this prescriber.
Other medical in Noblesville
- Dania SaltagiNoblesville$7K
- Meggie BeckleyIndianapolis$125K
- Jennifer ConnerIndianapolis$98K
- Brandon BoydCarmel$46K
- Karey DavisNew Castle$45K
- Sheryl NewCarmel$39K
- Lindsey GradyValparaiso$39K
- Jennifer IrwinIndianapolis$34K
- Dennae DaltonZionsville$33K
- Jenifer FortneyFort Wayne$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.